CardioComm Solutions Full Year 2024 Earnings: CA$0.001 loss per share (vs CA$0.001 loss in FY 2023)

CardioComm Solutions (CVE:EKG) Full Year 2024 Results

Key Financial Results

• Revenue: CA$526.7k (down 40% from FY 2023).
• Net loss: CA$194.6k (loss widened by 100% from FY 2023).
• CA$0.001 loss per share (in line with FY 2023).

Our free stock report includes 5 warning signs investors should be aware of before investing in CardioComm Solutions. Read for free now.

All figures shown in the chart above are for the trailing 12 month (TTM) period

CardioComm Solutions shares are down 33% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 5 warning signs for CardioComm Solutions you should be aware of, and 4 of them are significant.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.